Dunn, 1996 - Google Patents
In vitroα‐Complementation of β‐Galactosidase on a Bacteriophage SurfaceDunn, 1996
View PDF- Document ID
- 6113222674359806649
- Author
- Dunn I
- Publication year
- Publication venue
- European journal of biochemistry
External Links
Snippet
Surface display of large multimeric non‐secreted proteins is advantageous on the bacteriophage λ compared with the widely used filamentous phage systems. A model system, the α‐complementation of β‐galactosidase, was used for both further general …
- 102000005936 beta-Galactosidase 0 title abstract 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6852834B2 (en) | Fusion peptides isolatable by phase transition | |
| Dunn | Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein | |
| US5516637A (en) | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage | |
| Lecuit et al. | Internalin of Listeria monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization | |
| CA2610976C (en) | Use of stefin a as a scaffold protein | |
| US6790624B2 (en) | Coiled-coil mediated heterodimerization functional interaction trap | |
| AU2006200976B2 (en) | Method to screen peptide display libraries using minicell display | |
| US9498538B2 (en) | Translocation of non-natural chemical entities through anthrax protective antigen pore | |
| US7807782B2 (en) | Method for linking molecular substances | |
| US20090220455A1 (en) | Pharmaceutical compositions comprising elp fusion proteins | |
| Luzzago et al. | Isolation of point mutations that affect the folding of the H chain of human ferritin in E. coli. | |
| US20130053544A1 (en) | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds | |
| Eguchi et al. | Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles | |
| EP1248840A2 (en) | Circularly permutated, interaction-activated proteins | |
| CN110023328A (en) | Composition and method for protein expression and delivering | |
| AU731431B2 (en) | Materials and methods relating to inhibiting the interaction of p53 and mdm2 | |
| Dunn | In vitroα‐Complementation of β‐Galactosidase on a Bacteriophage Surface | |
| CN109311950A (en) | Compositions and methods for inhibiting WNT signaling | |
| JP2004516848A (en) | Modification targeting intracellular compounds | |
| US20040038317A1 (en) | Breakpoint fusion fragment complementation system | |
| Yong | Structure and Functional Characterization of ERG and SPOP | |
| Kong et al. | Display of aggregation‐prone ligand binding domain of human PPAR gamma on surface of bacteriophage lambda 1 | |
| CN118317972A (en) | Specific binding molecules for Fibroblast Activation Protein (FAP) | |
| EP0726951A1 (en) | Manufacture and use of polypeptides tagged using binding molecules | |
| Orwick | Role of specific transmembrane segment interactions in the insertion of a TetA helical hairpin containing an ionizable residue |